Claudia Fortuny | Antoni Noguera

on 10 May, 2013 6th Symposium and Tags: ,

Transferring HIV Infected Adolescents to an Adult Outpatient Clinic. What should we take care of?.

Read more

José A. Muñoz-Moreno | Daniel Podzamczer

on 10 May, 2013 6th Symposium and Tags: ,

Management of Neurocognitive Impairment in HIV Patients: Recommendations from the Recently Published Spanish Guidlines (GESIDA 2013).

Read more

J. Allen McCutchan

on 10 May, 2013 6th Symposium and Tags:

Obesity, Diabetes, and HIV: Intersecting Epidemic Contributing to NeuroAIDS?.

Read more

Scott Letendre

on 10 May, 2013 6th Symposium and Tags:

Controversies: Screening and Management of HAND.

Read more

Antoni Gual

on 10 May, 2013 6th Symposium and Tags:

Alcohol Use: Impact on HAND and Other Health Issues in HIV-Infected Patients, Screening and Management.

Read more

Ronald Ellis

on 9 May, 2013 6th Symposium and Tags:

Effect of Second Generation Antipsychotics on Metabolic and Vascular Risk Factors in HIV-infected Adults on Long Term Antiretroviral Therapy.

Read more

Juan V. Esplugues

on 9 May, 2013 6th Symposium and Tags:

A differential bioenergetic effect in human glia and neurons under treatment with the antiretroviral drug Efavirenz.

Read more

Daniel Podzamczer

on 9 May, 2013 6th Symposium and Tags:

Comparative Neuropsychiatric Profile of Dolutegravir and Efavirenz after 48w in treatment naïve patients: Data from ING114467 SINGLE study.

Read more

Mark Nelson

on 9 May, 2013 6th Symposium and Tags:

Switch from Efavirenz for CNS toxicity-UK experience.

Read more

Idil Kore

on 9 May, 2013 6th Symposium and Tags:

Neuropsychological performance in acute HIV: determinants of baseline performance and effects of immediate antiretroviral therapy

Read more